GlobeNewswire Inc.··NaTevogen Bio Tightens Capital Controls as Lead Investor Pledges Stake Stability
Tevogen Bio announces capital discipline measures including lead investor holding commitment, restricting share issuance to 1% of authorized shares, and targeting $50M+ revenue acquisitions.
TVGNTVGNWacquisitionscash flow positive